CliffBio
small molecule

ZTLIDO

LIDOCAINE

Loss of exclusivityMay 2031latest FDA-listed patent expiry
CompanyScilex Pharmaceuticals →View the full company profile on CliffBio

Drug detail

Brand nameZTLIDO
Active ingredientLIDOCAINE
Strength1.8%
Dosage formPATCH
RouteTOPICAL
ModalitySmall molecule
FDA approvalFebruary 2018
Marketing statusRX

Listed patents

PatentExpiresType
9925264May 2031product
11786455May 2031product
11793766May 2031use U-2267
9283174May 2031product
10765749May 2031product
9931403May 2031product
11278623May 2031product
10765640May 2031product

More from Scilex Pharmaceuticals

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

ZTLIDO patent cliff — loss of exclusivity May 2031 | CliffBio